SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-24
👔
NovaBridge Biosciences
@NBP_InsiderForm 4 Filing: Cao Sean Wuxiong Acquires (Grant) shares of $NBP
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
NovaBridge Biosciences
Ticker: $NBP
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-22
Shares: 362,570
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Cao Sean Wuxiong, holds the title of Chief Bus. Development Officer at NovaBridge Biosciences.
On 2026-06-22, the insider transacted 362,570 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Cao Sean Wuxiong (Chief Bus. Development Officer) was granted $0 of $NBP
Post-Transaction Position: 181,280 shares
SEC Accession No: 0002109966-26-000004 (CIK: 2109966)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.